The other cost of a watch that watches your heart: the worried well
A low-probability alert still sends most recipients to a doctor. Researchers are now naming the flip side of continuous self-monitoring — a device-driven health anxiety they call technohypochondria.
The case for a watch that monitors the heart is usually made in lives saved. The case against is quieter and harder to count: the anxiety, the clinic visits and the tests generated in people who turn out to be fine. A screening device that alerts even a small fraction of a very large population creates a large absolute number of worried users — and a body of research is now taking that cost seriously rather than treating it as the price of vigilance.
The numbers that make the worried well
The Apple Heart Study is the clearest illustration, because it measured the downstream behaviour directly. Of the 419,297 people enrolled, only 0.52% ever received an irregular-pulse notification [s1] — a deliberately low rate. But of the notified participants who returned a follow-up survey, 57% contacted a health care provider outside the study [s1]. And among those who wore a confirmatory ECG patch, atrial fibrillation was documented in just 34% [s1].
Put those together and the shape of the problem appears. Most people who act on an alert do not have the condition confirmed, yet a majority still seek care. Scale a 0.52% notification rate across the tens of millions of people who wear these watches and the number of appointments, ECGs and echocardiograms prompted by alerts that will not pan out is large — a screening cascade landing substantially on the healthy. The clinical term is the worried well: people made into patients by a test result rather than a symptom.
A named phenomenon
The psychological side of this is beginning to be formalised. A 2026 concept analysis, drawing on 1,240 sources across nursing, psychology and informatics, proposes the term "technohypochondria" for a device-driven health anxiety distinct from ordinary cyberchondria [s2]. Its three defining features, the authors argue, are a biometric-data obsession, a tendency to misinterpret and catastrophise the readings, and a need for continuous algorithmic feedback [s2]. Unlike the old pattern of anxiously searching symptoms online, this is a closed loop with a device that never stops producing numbers to check [s2].
The framing matters because it moves the anxiety from an incidental side effect to something with a mechanism. A wearable that quantifies heart rate, rhythm, oxygen and sleep gives an anxious mind an endless supply of ambiguous data points, each of which can be read as a threat. The feedback is constant, the interpretation is left to the user, and reassurance from one reading rarely lasts past the next.
Why hearts are a bad organ to worry about
Cardiac alerts are a particularly combustible case, because anxiety and the arrhythmia the watch is looking for are entangled. A systematic review of 84 studies found a bidirectional relationship between anxiety and atrial fibrillation: anxiety is common in patients with the arrhythmia, and it interacts with its onset, its recurrence and its treatment outcomes [s3]. For someone prone to health anxiety, a watch that flags an irregular pulse can therefore feed a loop — the alert raises anxiety, and the physiological effects of that anxiety, palpitations and a racing pulse, invite still more checking of the device that raised it.
Holding both truths
None of this argues that the watch's cardiac features are bad. For the person whose alert is real, early detection is a genuine benefit, and the ECG and notification features are cleared for exactly that prompt. The point is that the ledger has a second column. A tool that reduces one harm — missed disease — can increase another, in the form of anxiety and low-yield testing, and the two fall on different people.
For most wearers the practical response is temperance rather than abstinence: understanding that a single reading is a prompt, not a verdict; that reassurance-checking tends to worsen anxiety rather than resolve it; and that a device promising insight can, for some, deliver mostly unease. It is the same tension that shadows the rest of consumer health technology — the way sleep trackers can breed orthosomnia, a preoccupation with perfecting a number, and the way mental-health apps are easier to download than to benefit from. The watch measures the heart well enough. Whether that helps a given person depends on a variable it cannot read: how they hold the number it hands them.
Sources
- Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation — New England Journal of Medicine , November 14, 2019
- Techno-Hypochondria: A Concept Analysis of Wearable Technology-Induced Health Anxiety Among Healthcare Professionals — Healthcare (Basel) , July 2, 2026
- The Anxiety-AFib connection: a systematic review of mental health and arrhythmia interactions — Global Cardiology Science & Practice , June 30, 2026
More on
The Apple Heart Study enrolled 419,297 people. It is a screening tool, not a diagnosis.
Among watch wearers told their pulse looked irregular, a third had atrial fibrillation confirmed on a follow-up ECG patch. Most who were notified did not.
Smartwatches spot atrial fibrillation accurately. The catch is who is wearing them
A meta-analysis of 26 studies put pooled sensitivity at 95% and specificity at 97%. Samsung and Withings devices performed comparably to Apple — but the numbers come from people already suspected of arrhythmia.
What the Apple Watch ECG can and cannot detect, and the clearance it rests on
The FDA cleared it to sort one rhythm from one other. It cannot detect a heart attack, and about one reading in eight comes back inconclusive.
An AI ECG model found the one in ten older patients for whom AF screening paid off
A secondary analysis of the VITAL-AF trial reports a screening benefit only in the top risk decile — with a confidence interval whose lower bound sits at 0.01.